<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="20067">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01968811</url>
  </required_header>
  <id_info>
    <org_study_id>Avance A01</org_study_id>
    <nct_id>NCT01968811</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow Up Study of Avance Foam Abdominal Dressing Kit in Open Abdomen</brief_title>
  <official_title>A Multi-Centre, Post CE Mark, Open Clinical Investigation to Evaluate an Abdominal NPWT (Negative Pressure Wound Therapy) System (Avance® Pump and Avance® Foam Abdominal Dressing Kit) in Subjects With Open Abdominal Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation is a Post Marketing Follow-Up Study for the Avance Foam Abdominal Dressing
      Kit conducted as part of Mölnlycke Health Care's quality system. The primary objective is to
      evaluate the dressing kit as part of a negative pressure system. The secondary objectives
      are to collect and evaluate safety data, performance data and information on technical
      complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of participants with Adverse events as a Measure of Safety and tolerability.</measure>
    <time_frame>participants will be followed until abdominal closure or until insertion of synthetic mesh, an expected avarage of 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Fascial/Skin closure of the open abdomen</measure>
    <time_frame>At end of treatment, an expected average is 10 days.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Open Abdomen</condition>
  <arm_group>
    <arm_group_label>Avance foam, abdominal dressing kit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Avance Foam dressing kit</intervention_name>
    <arm_group_label>Avance foam, abdominal dressing kit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provision of written informed consent from subject or family member

          2. Subjects with open abdomen suitable for temporary closure with NPWT therapy

          3. Subjects where the viscera and/or abdominal organs need to be protected by an
             abdominal organ contact layer (OCL)

          4. Subject which (at the time of the baseline visit) are planned to be cared for between
             dressing changes at Intensive Care Unit

          5. Male or female, 18 years and above

        Exclusion Criteria:

          1. Synthetic mesh inserted in the abdomen

          2. Non-enteric fistulae or unexplored fistulas

          3. Untreated osteomyelitis

          4. Malignant wounds

          5. Abdominal  wall hernia

          6. Subjects previously treated with an NPWT abdominal dressing

          7. Known allergy or hypersensitivity to any of the components in the dressing

          8. Pregnancy

          9. Subjects not suitable for the investigation according to the investigator's judgement

         10. Subjects included in other ongoing clinical investigation at present which could
             interfere with this investigation, as judged by the investigator
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sahlgrenska University hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>October 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
